HanchorBio Inc to Speak at ACCESS ASIA Partnering Forum | Online Showcase

September 25, 2025 (9:30 AM CST) — We’re pleased to announce that Henry Ye, Associate Business and Development Director of HanchorBio Inc, will present at the ACCESS Asia Partnering Forum Online Showcase. ACCESS Asia builds on the success of ACCESS China, expanding Asia’s leading cross-border biotech platform to connect innovators with global pharma, investors, and partners

About HanchorBio Inc

HanchorBio is a biopharmaceutical company headquartered in San Francisco with sites in Taipei and Shanghai, developing next-generation personalized immunotherapies through its proprietary Fc-based Designer Biologics (FBDB™) platform. The company’s pipeline includes HCB101, a potentially best-in-class dual-functional SIRPα-Fc fusion protein in Phase 1a for solid and hematologic tumors, and HCB301, a first-in-class tri-specific biologic (anti-PD-L1 x SIRPα x TGFβRII) now enrolling patients in the U.S. following IND approvals in both the U.S. and China. By harnessing innate and adaptive immunity with multi-targeting modalities, HanchorBio is advancing transformative medicines for cancer and other debilitating diseases.

About the Speaker

Mr. Ye drives Business Development and Corporate Strategy at HanchorBio, leveraging over 14 years of consulting and BD experience in the biopharmaceutical industry. He has previously contributed to the growth of Reistone, Phaeno Thera, Eddingpharm, and ChinaBio Group, where he built expertise in advancing partnerships and shaping strategic initiatives to accelerate innovation and growth.

About ACCESS ASIA Partnering Forum

ACCESS Asia Partnering Forum Online Showcase is scheduled to be held on September 25, 2025, 9:30 AM (China Standard Time) via Zoom.
This event will spotlight the 1st wave of 100 innovators, providing them with a global stage to showcase pipelines and connect with pharma, investors, and strategic partners worldwide.

Conference Name: ACCESS Asia Partnering Forum Online Showcase
Date & Time: September 25, 2025, 9:30 AM (China Standard Time)
View more information at: https://biotochina.org/